Autism Spectrum Disorder: Pharmacological Management

Autism spectrum disorder is a neuro-developmental disorder characterized by deficits in social communication and social reciprocity, as well as repetitive behavior and restricted interests. 

First line treatment is non-pharmacological based on behavioral modification strategies. This post will briefly summarize the pharmacological management of autism spectrum disorder in the following diagram:

Physician’s Guide for Clinical Psychiatry course contains more detailed information on this topic in following chapter:

(THIS CHAPTER IS AVAILABLE FOR FREE PREVIEW)

This chapter will summarize the treatment options for following co-morbid symptoms in autism spectrum disorder (medications rated from high to low benefit rating):

  1. Agitation and irritability.

  2. Anxiety.

  3. Depression.

  4. Attention, Hyperactivity and Cognition.

  5. Sensory sensitivity.

  6. Tics/ abnormal movements.

  7. Insomnia: (a) falling asleep, (b) staying asleep.

  8. Self injury.

  • Total chapters= 230 and counting.

  • Each chapter includes references (with full pdf article or PubMed link for each article).

  • Course is frequently updated with new chapters.

  • Triweekly Email Clinical Summary: Subscribers receive 3 emails/week containing chapters clinical summary (Mon, Wed, and Fri).

  • Goal is to have all important clinically relevant topics in one course: aimed at busy clinical professionals for quick review.

Related Articles

Journal Club #11: International Trauma Questionnaire (ITQ) for PTSD Assessment.

Journal Club #11: International Trauma Questionnaire (ITQ) for PTSD Assessment. Article: Br J Psychiatry. 2020;216(3):132‐137. <a href=”https://psychiatryeducationforum.teachable.com/courses/journal-club/lectures/23902161″ target=”_blank” rel=”noopener noreferrer”> <img width=”640″ height=”213″ src=”https://psychiatryeducationforum.com/project1/wp-content/uploads/2020/08/Black-and-White-General-Greeting-Liberation-Day-Twitter-Header-1-1024×341.png” alt=””…